FindTrial
Sign In

A study on efficacy of combined Chinese and Western medicine and follow-up of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19)

A study on efficacy of combined Chinese and Western medicine and follow-up of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040770
Enrollment
Unknown
Registered
2020-12-09
Start date
2020-01-10
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:None

Sponsors

Public Health Clinical Center of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients hospitalized in Xi'an eighth hospital due to covid-19 from January to December 2020: 1. Sign informed consent; 2. The patient was diagnosed as covid-19 during hospitalization and was discharged alive; 3. Complete clinical data during hospitalization.

Exclusion criteria

Exclusion criteria: Too old to move or take care of themselves, or who cannot get to the Public Health Clinical Center of Chengdu Hospital for examination.

Design outcomes

Primary

MeasureTime frame
nucleic acid tests;Blood routine;liver and kidney function;blood glucose testing;chest CT;echocardiography;—

Countries

China

Contacts

Public ContactWu Guihui

Public Health Clinical Center of Chengdu

3119213561@qq.com+86 13056668540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026